Leaders in
NEUROMODULATION TECHNOLOGY
ABOUT
Valencia Technologies is a neuromodulation company transforming the standard of care for bladder dysfunction.
Market Innovation
The company’s implantable neuromodulation technology is reshaping the delivery of long term therapy for bladder control. eCoin® is a tibial implant for Urge Urinary Incontinence (UUI). The coin sized neurostimulator is placed under the skin near the ankle during a consistent, minimally invasive procedure using only local anaesthetic.
The eCoin® device provides automatic stimulation on the tibial nerve via a forgiving dome shaped field. eCoin eliminates lead wires optimized by precise placement, patient management of the device with external remotes, recharge requirements, general anesthesia or sedation with placement.
Location
The company is headquartered in Valencia, California and is backed by leaders in healthcare technology and neurostimulation therapy.
ABOUT eCoin®
Minimally Invasive
• Effective Leadless Neurostimulation Therapy for UUI
• Drug Free Relief for People with Urge Urinary Incontinence
eCoin® is FDA Approved – Important Safety Information
LEADERSHIP
Jeff Greiner
Chairman of the Board
Founder of Valencia Technologies. Previously was long-term CEO of Advanced Bionics (AB). Al Mann founded AB and appointed Jeff as CEO to lead a team of seven engineers and scientists. Led AB from Phase 1 clinical trials to over $300M in annual revenue; 2,500 employees. Sold the business to Boston Scientific and Sonova for gross proceeds of ~$3 billion. LLM from George Washington, JD from UCLA and BS in Economics from the United States Air Force Academy.
Russ Ramanayake
Vice President of Finance
More than 25 years of corporate experience in medical devices including M&A, Divestures and IPOs, Previous Corporate Controller for Second Sight Medical products and played a key role in successful completion of IPO in 2014…
Erik Styacich
Vice President of Sales
17+ years of experience in the Med Tech industry, with the majority of that time spent in Urology and Neuromodulation. Prior to VTC, Erik led sales teams in the Interventional Urology business unit (Urolift) at Teleflex, Nuvectra Medical…
Ann Decker
Vice President of Reimbursement and Health Policy
30 years in health care industry with over 25 in medical device reimbursement and health policy strategy. Former VP of Reimbursement & Health Policy at Teleflex.
Nicole Barber
VP of Regulatory & Clinical Affairs
19 years of experience in implantable medical devices. Former VP of Regulatory Affairs and Compliance Officer at CeloNova BioSciences and previous experience in Regulatory Affairs at Genentech, Osseon…
JOIN THE TEAM
Valencia Technologies is led by neuromodulation pioneers who have successfully scaled biotech companies from infancy to $300M in annual revenue.
CONTACT US
Drop us a line to connect and learn more about Valencia Technologies.
PRESS / MEDIA
CMS Publication of 2025 Medicare Proposed Rule for eCoin® Procedure
VALENCIA, Calif., July 11, 2024 /PRNewswire/ -- Valencia Technologies Corporation [...]
Implantable Tibial Nerve Stimulation added as Treatment Option within AUA/SUFU 2024 OAB Guideline
VALENCIA, Calif., May 2, 2024 /PRNewswire/ -- Valencia Technologies is pleased to [...]
Anthem Blue Cross and Blue Shield Announces Coverage for the eCoin System for Urinary Incontinence
VALENCIA, Calif., Jan. 9, 2024 /PRNewswire/ --Valencia Technologies Corporation announced today that [...]
Follow Our Social Media
Join us on your favorite social platform.
Valencia
Technologies
28464 Westinghouse Place
Valencia, CA 91355
United States
Email: [email protected]
Website: valenciatechnologies.com
Corporate Office: (661) 775-1414
Administration Office: (661) 505-7264
Customer Service Help Desk: (833)-326-4687
Corporate Office: (661) 775-1414
Administration Office: (661) 505-7264
Customer Service Help Desk: (833)-326-4687